Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegaspargase in Relapsed/Refractory Ovarian Cancer
NCT01313078Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2010
- Primary completion
- Sep 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started Jan 2010; status: completed.
02
Drugs
pegaspargase
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01313078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313078.